NON-DISCLOSURE, INTELLECTUAL PROPERTY, NON-COMPETITION AND NON-SOLICITATION AGREEMENTNon-Disclosure, Intellectual Property, Non-Competition and Non-Solicitation Agreement • February 14th, 2023 • Chembio Diagnostics, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2023 Company IndustryThis Non-Disclosure, Intellectual Property, Non-Competition And Non-Solicitation Agreement (the “Agreement”) is entered into as of March 16, 2020 between Chembio Diagnostics, Inc. (the “Company”) and Richard L. Eberly (the “Executive,” and, together with the Company, the “Parties”).
NON-DISCLOSURE, INTELLECTUAL PROPERTY, NON-COMPETITION AND NON-SOLICITATION AGREEMENTNon-Disclosure, Intellectual Property, Non-Competition and Non-Solicitation Agreement • February 14th, 2023 • Chembio Diagnostics, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2023 Company IndustryThis Non-Disclosure, Intellectual Property, Non-Competition and Non-Solicitation Agreement (the “Agreement”) is entered into on January 5, 2022 between Chembio Diagnostics, Inc., a Nevada corporation (the “Company”), and Lawrence J. Steenvoorden (the “Executive” and, together with the Company, the “Parties”). This Agreement is entered into in accordance with the Employment Agreement entered into by the Parties on December 30, 2021 and effective as of the date hereof (the “Employment Agreement”).